Pharmaceutical Executive Europe - October 2008 - (Page 16)

Executive recruitment increasingly face a real skills/knowledge deficit when they do need it. Not being able to access such staff expeditiously is emerging as one of the largest threats to drug development programmes, not least in the reduced ability to react and deliver expertise to deal quickly with an opportunity or a problem — or even simply deal with planned capacity issues — as the programmes go through their various stages. Pharma has previously coped with this by shuffling staff around, but it no longer has this flexibility. This need to react quickly and effectively will increase as we enter the biologics era, but the option of investing in permanent staff for single or intermittent issues is both costly and takes time to achieve. Creating reliable systems that provide such expertise, while maintaining continuity within the company and lowering the overall costs of servicing the smaller numbers of drugs, is now critical. Most mainstream pharmaceutical companies are investing in plans for outsourcing core technologies and knowledge-based expertise, following on from the relatively successful outsourcing of more basic, routine tasks such as data entry and monitoring. They have seen how biotechs, which have never been able to afford big expert groups in-house, have had to rely heavily on external expertise or collaborations, and now want to outsource/insource up to 50% of their high- and medium-level activities. The critical issue is how to do that in a structured way, while maintaining the quality and skills development of the individuals concerned, and keeping critical core knowledge and continuity in-house. Even large CROs struggle to provide such expertise as it is incompatible with their business model. Currently, it is only accessible externally through small consultancy groups, freelancers or interims in an uncoordinated, usually un-integrated manner, and it can be difficult to change direction in a timely or cost-effective fashion. This is particularly the case when: Educational resources for all your promotional needs Oxford University Press provide the ideal solution to your promotional needs. We offer a range of specialist publishing services, from bulk purchases and branded publications to chapter reprints. There are over 2,000 titles to choose from, including the renowned Oxford Handbooks series, and a range of specialist Oxford Medical Libraries focused around key therapy areas, including: • • • • • General Practice Oncology Neurology Cardiology Diabetes • • • • • Pain Management Psychiatry Anaesthesia Rheumatology Respiratory Medicine Figure 1 Future revenue hits. 20 18 16 14 $ billion 12 10 8 6 4 2 0 2008 2009 2010 2011 2012 $2.8 $6.5 $15.0 $15.2 $18.7 All Oxford Medical Library titles are fantastic value, priced at just £5.99, and are available with our full range of publishing services. To discuss how your company can benefit, please contact: Mark Whiting Corporate Medical Sales Tel: +44 (0) 1865 353498 Email: corporatesales.uk@oup.com 1 19 Meet unmet needs Natalie Douglas on named patient programmes 22 Pharma in Turkey Interviews with the country’s leading executives 37 Last words Who said what in pharma’s last four weeks 3 News The monthly round-up of European stories http://www.oup.co.uk

Table of Contents Feed for the Digital Edition of Pharmaceutical Executive Europe - October 2008

Pharmaceutical Executive Europe - October 2008 Contents News and Analysis Calendar BioFutures Strategy Fundamentals Executive Recruitment: Small Company, Big Career Executive Recruitment: Instant Pharma Named Patient Programmes Executive Review: Turkey

Pharmaceutical Executive Europe - October 2008

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.